ECLS Bridge to Lung Transplantation Optimizing and Ambulating the Recipient
|
|
- Stephany Lee
- 5 years ago
- Views:
Transcription
1 ECLS Bridge to Lung Transplantation Optimizing and Ambulating the Recipient Shaf Keshavjee MD MSc FRCSC FACS Surgeon-in-Chief, University Health Network James Wallace McCutcheon Chair in Surgery Director, Toronto Lung Transplant Program Professor, Division of Thoracic Surgery and Institute of Biomaterials and Biomedical Engineering, Vice Chair, Innovation, Department of Surgery University of Toronto
2 Disclosure Founding Partner: Perfusix Canada Inc. (CSO) Perfusix USA Inc. (Lung Bioengineering /UT) XOR Labs Toronto Inc. (CSO) XVIVO Perfusion Research support and clinical trial United Therapeutics Research support and clinical trial Xenios/Fresenius Research support and investor in XOR
3 ECLS Bridge to Lung Transplant ECLS bridge to LTx is being increasingly applied UNOS database analysis J Thorac Dis Aug;6(8):
4 Selection of Large Published Series Center year # of pts ECLS duration** Successful bridge to LTx 1-year survival of transplanted pts Hannover d 62% 80%* Lexington # d NA 93% Pittsburgh d 78% 74% Munich d 50% 54% Zurich d 86% 68% Columbia d 56% 90% Vienna d 89% 67% Toronto d 89% 76% * 6-months survival # multicenter study ** med vs. mean 4
5 Toronto Experience To review our experience of ECLS in patients bridged to LTx lessons learned To identify factors related to optimal bridging 5 J Thoracic Cardiovasc Surg 2017
6 Indications for ECLS Bridging Indications: severe hypercapnic + hypoxemic failure or hemodynamic failure (PPH) Candidacy for ECLS bridging is discussed by a multidisciplinary team in advance at the time of listing Exclusion (relative?) criteria: age > 65 years severe deconditioning BMI > 30 significant comorbidities (coronary artery disease, etc.) prolonged mechanical ventilation uncontrolled sepsis and other multi-organ dysfunction (except isolated kidney failure or liver dysfunction associated with PH) 6
7 Bridging Strategy Hypercapnic failure Hypoxic failure RV failure PH RV+LV failure Novalung Hemolung Single-cannula VV ECMO dual-cannula VV ECMO VA ECMO PA/LA Novalung 7
8 COUNT (n) Toronto Experience: Total Lung Transplants by Type (BLT, SLT, HLT) YEAR BLT SLT H/L 8
9 ECLS activities by Indication/Year /2016 (YTD)* No. of ECLS/year 90 Cardiac / Other 80 ARDS (non-tx) BTR (Post) 70 BTT (pre) Year 9
10 10 Percentage of Patients Bridged to LTx
11 Evolution in Practice VV VV VV VA
12 CF 23 yo female pco mmhg ph 7.18 Continuous BIPAP pco 2 68 mmhg ph 7.42
13 29 yo male CLAD, Hypercapnia
14 91 days on VV ECMO prior to Re-LTx
15 Discharge - going home and ambulatory!
16
17 Ambulation 37% were able to do physical therapy during bridging full ambulatory standing/stepping dangle bed exercises immobile full ambulatory standing/stepping dangle bed exercises immobile 17
18 Bridging Devices and Success of Extubation: Is Tracheostomy Better Than Extubation? Mean time of ECLS bridging: 14 days (range 0-95) Hemolung Novalung Single cannula VV ECMO Two cannula VV ECMO VA ECMO PA/LA Novalung Multiple devices extubated tracheostomized intubated 18
19 32 yo female with Cystic Fibrosis
20 Past Medical History 32yo female Cystic Fibrosis Chronically infected with Pseudomonas Progressive drop in lung function over last year (FEV 1 1.4L) Frequent exacerbations IV antibiotics and steroid Considering lung transplant assessment but doing relatively well Exocrine pancreatic insufficient, CF related diabetes, DIOS Married, 3 yo daughter
21 Current Medical History Mar 2, 2016: Acute worsening of SOB, hypoxemia; FEV 1 dropped to 0.79L (23% Pred) Mar 9, 2016 Developed H1N1 pneumonia treated with Tamiflu Respiratory failure on BIPAP at outside hospital - developed worsening hypercapnia Apr 7, 2016 Intubated and transferred to TGH for urgent lung transplant assessment /bridge to LTx Apr 7, 2016 on admission
22 Assessment Summary Cardiac Echo: Normal sized LV with moderate LV dysfunction LVEF estimated at 30-40% Normal sized RV with mildly reduced function Enable to estimate RVSP ABG: ph 7.30, pco2 121, po2 216 (Apr 7 on ICU arrival) TLC (P): 5.5 (L) LAB DATA: Cr: 57 AST: 15 ALT: 18 ALP: 144 BILT: 3 INR: 1.05 ALB: 24 HbA1C: Hb: 93 WBC: 24.0 Plt: 272 Listed on Apr 8, 2016 Status 2, Bilateral only
23 VV-ECMO for bridge to recovery/ bridge to lung transplant After admission to ICU Resp. condition deteriorated acutely ph 7.16, pco2 >140, po2 87 VV-ECMO was placed via 22 Fr RIJ and 25 Fr RF Tracheostomy After ECMO insertion Apr 7 Apr 8 Apr 15 ABG: ph 7.27 pco2 61 po2 67 Gradually Deteriorated, Needed increased ECLS Flow
24 Septic Shock and Persistent Bacteremia Developed septic shock Bacteremia with gram-negative Pseudomonas 3 vasopressors at maximum dose VASOPRESSIN, LEVOPHED, and ADRENALIN Despite VV ECMO (flow of 7 L/min), Significant hypoxemia (without pump recirculation) ABG: ph 7.14 pco2 52, po2 60 Refractory vasodilation - sepsis April 17, 2016
25 Remove the Septic Source: Bilateral Pneumonectomy Switch to Central VA-ECMO (22Fr aortic cannula, 34/46 two-stage IVC venous cannula Right-sided pneumonectomy first, then left pneumonectomy Insertion of Right lung PA-LA Novalung Outflow: Pulmonary arterial (34 Fr single-stage venous cannula) Inflow: right superior pulmonary vein (28 Fr Pacifico) April 17, 2016
26 Remove Septic Source: Bilateral Pneumonectomies
27
28 Bilateral Lung Transplant April 22, 2016 (5 days after pneumonectomy) On central VA-ECMO Left side implantation first ( CIT: 3h 15 min, WIT: 49 min) Removed the PA cannula from right PA (for the PA-LA Novalung) Removed the LA cannula from right superior pulmonary vein Right lung implantation ( CIT: 4h 45 min, WIT: 50 min) 6 U prbc and 2 U platelets Immediate Postop BLT
29 October 2016 J Thor Cardiovasc Surg 2016 Oct 19, 2016
30 Toronto Experience Retrospective analysis of our institutional ECLS bridging practice over the last 10 years January September 2016 Total 1111 LTx 71 patients bridged to LTx 30
31 Outcomes Bridged patients Total n=71 Survived until LTx - yes 63 (89%) - no 8 (11%) PGD at 72hrs - PGD 0/1 9% - PGD 2 33% - PGD 3 57% Postoperative ECMO - no 36 (59%) - VV ECMO 16 (26%) - VA ECMO 9 (15%) Time to extubation (median, IQR) 18 (4;33) Total hospital days (median, IQR) 72 (50;122) 31
32 Outcomes Bridged patients Total n=71 Survived until LTx - yes 63 (89%) - no 8 (11%) PGD at 72hrs - PGD 0/1 9% - PGD 2 33% - PGD 3 57% Postoperative ECMO - no 36 (59%) - VV ECMO 16 (26%) - VA ECMO 9 (15%) Time to extubation (median, IQR) 18 (4;33) Total hospital days (median, IQR) 72 (50;122) 32
33 Outcomes Bridged patients Total n=71 Survival per intention-to-treat Survived until LTx - yes 63 (89%) - no 8 (11%) 70% bridged to LTx bridged to Re-LTx PGD at 72hrs - PGD 0/1 9% - PGD 2 33% - PGD 3 57% 53% 63% 51% Postoperative ECMO - no 36 (59%) - VV ECMO 16 (26%) - VA ECMO 9 (15%) Time to extubation (median, IQR) 18 (4;33) Total hospital days (median, IQR) 72 (50;122) 32% 32% p=
34 Successful vs. Unsuccessful bridging No differences in: age, diagnosis, first/re-transplant, type of device, time on ECLS BUT!!! successful bridging unsuccessful bridging p-value n=63 n=8 Ventilation during bridging - no invasive MV 31 (49%) 1 (13%) Ambulatory status - mobile/awake 25 (40%) 1 (13%)
35 Comparison of Bridged pts to LTx w/o Bridging Bridge to LTx LTx without Bridging n=71 n=1040 p-value Age (mean; range) 38 (18-62) 53 (18-77) < Gender (m/f) 48%/52% 58%/42% Height (mean±sd; cm) 165.3± ± Weight (mean±sd; kg) 62.3± ± BMI (mean±sd; kg/m 2 ) 22.4± ± Diagnosis (n; %) - COPD 3% 22% - Interstitial lung disease 37% 38% - Cystic Fibrosis 23% 16% - Pulmonary hypertension 18% 3% < CLAD 16% 2% - others 4% 19% Type of LTx - Double-LTx 92% 81% - Single-LTx 5% 18% < Heart-Lung Tx 3% 1% 35
36 Comparison of Bridged pts to LTx w/o Bridging Bridge to LTx LTx without Bridging n=71 n=1040 p-value Age (mean; range) 38 (18-62) 53 (18-77) < Gender (m/f) 48%/52% 58%/42% Height (mean±sd; cm) 165.3± ± Weight (mean±sd; kg) 62.3± ± BMI (mean±sd; kg/m 2 ) 22.4± ± Diagnosis (n; %) - COPD 3% 22% - Interstitial lung disease 37% 38% - Cystic Fibrosis 23% 16% - Pulmonary hypertension 18% 3% < CLAD 16% 2% - others 4% 19% Type of LTx - Double-LTx 92% 81% - Single-LTx 5% 18% < Heart-Lung Tx 3% 1% 36
37 Bridge to Lung Transplant Survival IPF CF PPH CLAD survival 37
38 Comparison of Bridged Pts to LTx w/o Bridging Survival after LTx Survival after Re-LTx LTx without bridging bridged to LTx Re-LTx without bridging bridged to Re-LTx 38
39 Successful ECLS Bridge to LTx 1. Patient Selection 2. Avoid prolonged mechanical ventilation pre- ECLS 3. Provide appropriate pump support 4. Avoid groin cannulation if possible 5. Ambulatory and non intubated preferred (but avoid lung de-recruitment) 6. Nutritional support, consider early tracheostomy 7. Need an engaged AND persistent multidisciplinary team
40 Take Home Messages ECLS bridge to first lung transplant leads to very good short and long-term outcomes Bridge to re-transplantation requires strict patient selection RAS appears to be a higher risk group Successful bridging is associated with ambulation and weaning from mechanical ventilation 40
41
ECLS as Bridge to Transplant
ECLS as Bridge to Transplant Marcelo Cypel MD, MSc Assistant Professor of Surgery Division of Thoracic Surgery Toronto General Hospital University of Toronto Application of ECLS Bridge to lung recovery
More informationExtracorporeal Life Support (ECLS) as a Bridge to Decision in Lung Transplantation
Extracorporeal Life Support (ECLS) as a Bridge to Decision in Lung Transplantation Gabriel Loor, MD Baylor St. Lukes Medical Center Surgical Director Lung Transplantation Co-chief Section of Adult Cardiac
More informationECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
More informationMarcelo Cypel MD MSc
Ex vivo Organ Repair Marcelo Cypel MD MSc Canada Research Chair in Lung Transplantation Surgical Director ECLS Program UHN Assistant Professor of Surgery Division of Thoracic Surgery University Health
More informationOptimizing the Donor Lung with EVLP
Optimizing the Donor Lung with EVLP Marcelo Cypel MD MSc FRCSC Canada Research Chair in Lung Transplantation Surgical Director ECLS Lung Program UHN Associate Professor of Surgery Division of Thoracic
More informationOutcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016
Outcomes From Severe ARDS Managed Without ECMO Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016 Severe ARDS Berlin Definition 2012 P:F ratio 100 mm Hg Prevalence:
More informationRight Ventricular Failure: Prediction, Prevention and Treatment
Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:
More informationIndications for prolongation of ECMO into the early postoperative period in lung transplantation How we do it
Indications for prolongation of ECMO into the early postoperative period in lung transplantation How we do it W Klepetko, MD Professor of Thoracic Surgery HEAD: DIVISION OF THORACIC SURGERY MEDICAL UNIVERSITY
More informationArtificial Lungs: A New Inspiration
Artificial Lungs: A New Inspiration Joseph B. Zwischenberger MD Johnston-Wright Professor and Chairman: Department of Surgery j.zwische@uky.edu The University of Kentucky Lexington, Kentucky Presenter
More informationManagement of Respiratory Failure: The Surgical Perspective. When Traditional Respiratory Support Techniques fail. ARDS: Evidence Based Practice
Critical Care Medicine and Trauma Management of Respiratory Failure: The Surgical Perspective Jasleen Kukreja, M.D. Division of Cardiothoracic Surgery University of California San Francisco When Traditional
More information06/04/2013 ISHLT. 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013
LUNG TRANSPLANTS The Journal of Heart and Lung Transplantation, 2012 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013 LUNG TRANSPLANTATION:STATE OF THE ART L. Santambrogio
More informationExtracorporeal support in acute respiratory failure. Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London
Extracorporeal support in acute respiratory failure Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London Objectives By the end of this session, you will be able to: Describe different
More informationThe Association Between Oxygenation Thresholds and Mortality During Extracorporeal Life Support
The Association Between Oxygenation Thresholds and Mortality During Extracorporeal Life Support Laveena Munshi, MD, MSc November 1, 2016 Critical Care Canada Forum Interdepartmental Division of Critical
More informationCardiovascular Institute
Allegheny Health Network Cardiovascular Institute Extracorporeal Membrane Oxygenation (ECMO) Program Our patient survival rate is higher than the national average. ECMO experts. Multidisciplinary team.
More informationECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest
ECMO: a breakthrough in care for respiratory failure? PD Dr. Thomas Müller Regensburg no conflict of interest 1 Overview Mortality of severe ARDS Indication for ECMO PaO 2 /FiO 2 Efficiency of ECMO: gas
More informationEXTRA CORPOREAL MEMBRANE OXYGENATION
EXTRA CORPOREAL MEMBRANE OXYGENATION Basic Overview and Case Study Bob Hayes, Chief Perfusionist Enloe Medical Center Jenny Humphries, RN, BSN, MBA, CFRN Chief Flight Nurse, Enloe FlightCare Normal Cardiopulmonary
More informationLung Transplant Case Presentation
Lung Transplant Case Presentation Errol L. Bush, MD Assistant Professor of Surgery Heart and Lung Transplantation UCSF Medical Center Update in Advanced Lung Disease May 9, 2015 LP 47y F never smoker w/
More informationJennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio
Biventricular Heart Failure Advanced Treatment Options at The Cleveland Clinic Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio I have no disclosures. Examine respiratory and
More informationManaging an Organ - New Therapies
Managing an Organ - New Therapies Marcelo Cypel MD MSc Canada Research Chair in Lung Transplantation Surgical Director, ECLS program UHN Assistant Professor of Surgery Division of Thoracic Surgery University
More informationCase scenario V AV ECMO. Dr Pranay Oza
Case scenario V AV ECMO Dr Pranay Oza Case Summary 53 y/m, k/c/o MVP with myxomatous mitral valve with severe Mitral regurgitation underwent Mitral valve replacement with mini thoracotomy Pump time nearly
More informationArtificial Lung: A New Inspiration
Artificial Lung: A New Inspiration Joseph B. Zwischenberger MD Johnston-Wright Professor and Chairman: Department of Surgery j.zwische@uky.edu The University of Kentucky Lexington, Kentucky Presenter Disclosure
More informationAdult Extracorporeal Life Support (ECLS)
Adult Extracorporeal Life Support (ECLS) Steven Scott, M.D., F.A.C.S. Piedmont Heart Institute Cardiothoracic Surgery Disclosures None ECMO = ECLS A technique of life support that involves a continuous
More informationLung Transplantation A look Inside A Surgeon s Perspective
Lung Transplantation A look Inside A Surgeon s Perspective Hassan Nemeh, MD Henry Ford Hospital Michigan Society of Respiratory Care Spring Conference 2016 Historical background Alexis Carrel 1905 Reported
More informationThe Role of ECMO in Thoracic Surgery. Matthew Hartwig, MD
The Role of ECMO in Thoracic Surgery Matthew Hartwig, MD Disclosure Slide Consultant for Mallincrodkt and Quark Pharmaceuticals Case #1 28 y.o. female with tracheal mass No previous medical or surgical
More informationAllinaHealthSystem 1
: Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support
More informationInnovative ECMO Configurations in Adults
Innovative ECMO Configurations in Adults Practice at a Single Center with Platinum Level ELSO Award for Excellence in Life Support Monika Tukacs, BSN, RN, CCRN Columbia University Irving Medical Center,
More informationLong Term Support for Respiratory Failure: VV ECMO or Oxygenated RVAD?
Long Term Support for Respiratory Failure: VV ECMO or Oxygenated RVAD? Mechanical Circulatory Support Symposium 2018 (Houston, TX) Charles Hoopes, MD Professor of Surgery University of Alabama (Birmingham)
More informationExtracorporeal membrane oxygenators (ECMO) provide
Case Report Interhospital Transport of the ECMO Patients in Bangkok Hospital Abstract An extracorporeal membrane oxygenator (ECMO) is used to support the heart and lungs in patients with severe cardiogenic
More informationCase - Advanced HF and Shock (INTERMACS 1)
Case - Advanced HF and Shock (INTERMACS 1) Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director,
More informationInitial Experience With Single Cannulation for Venovenous Extracorporeal Oxygenation in Adults
Initial Experience With Single Cannulation for Venovenous Extracorporeal Oxygenation in Adults Christian A. Bermudez, MD, Rodolfo V. Rocha, MD, Penny L. Sappington, MD, Yoshiya Toyoda, MD, PhD, Holt N.
More informationProne ventilation revisited in H1N1 patients
International Journal of Advanced Multidisciplinary Research ISSN: 2393-8870 www.ijarm.com DOI: 10.22192/ijamr Volume 5, Issue 10-2018 Case Report DOI: http://dx.doi.org/10.22192/ijamr.2018.05.10.005 Prone
More informationHeart-lung transplantation: adult indications and outcomes
Brief Report Heart-lung transplantation: adult indications and outcomes Yoshiya Toyoda, Yasuhiro Toyoda 2 Temple University, USA; 2 University of Pittsburgh, USA Correspondence to: Yoshiya Toyoda, MD,
More informationECMO Primer A View to the Future
ECMO Primer A View to the Future Todd J. Kilbaugh Assistant Professor of Anesthesiology, Critical Care Medicine, and Pediatrics Director of The ECMO Center at the Children s Hospital of Philadelphia Disclosures
More informationARDS: an update 6 th March A. Hakeem Al Hashim, MD, FRCP SQUH
ARDS: an update 6 th March 2017 A. Hakeem Al Hashim, MD, FRCP SQUH 30M, previously healthy Hx: 1 week dry cough Gradually worsening SOB No travel Hx Case BP 130/70, HR 100/min ph 7.29 pco2 35 po2 50 HCO3
More informationDisclosures. Transplanting Interstitial Lung Disease. Lung Transplantation. Indications. I have nothing to disclose. Adult Lung Transplants
Transplanting Interstitial Lung Disease Steven Hays, MD Associate Professor Medical Director, Lung Transplantation UCSF Medical Center Disclosures I have nothing to disclose Adult Lung Transplants Number
More informationThe Utility of Extravascular Lung Water Measurements Following Bilateral Lung Transplant
The Utility of Extravascular Lung Water Measurements Following Bilateral Lung Transplant Laveena Munshi, MD, MSc November 2018 Interdepartmental Division of Critical Care Medicine Mount Sinai Hospital/University
More informationExtra Corporeal Life Support for Acute Heart failure
Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical
More informationVeno-Venous ECMO Support. Chris Cropsey, MD Sept. 21, 2015
Veno-Venous ECMO Support Chris Cropsey, MD Sept. 21, 2015 Objectives List indications and contraindications for ECMO Describe hemodynamics and oxygenation on ECMO Discuss evidence for ECMO outcomes Identify
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationOptimal Intraoperative support
Optimal Intraoperative support (Pump vs No Pump, CPB vs ECMO) W Klepetko, MD Professor of Thoracic Surgery Head: DIVISION OF THORACIC SURGERY MEDICAL UNIVERSITY OF VIENNA www.meduniwien.ac.at/thoraxchirurgie
More informationCanadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet
Canadian Trauma Trials Collaborative STUDY CENTRE: Institution: City / Province: / Occult Pneumothorax in Critical Care (OPTICC): Standardized Sheet PATIENT DEMOGRAPHICS: First Name: Health record number
More informationRecognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support
Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support Mahir Elder, MD, FACC,SCAI Medical Direct of PERT program Medical Director of Endovascular medicine Clinical Professor
More information10/16/2017. Review the indications for ECMO in patients with. Respiratory failure Cardiac failure Cardiorespiratory failure
Review the indications for ECMO in patients with Respiratory failure Cardiac failure Cardiorespiratory failure 1 Extracorporeal membrane lung and/or cardiac support. A support therapy, in no way definitive.
More informationERJ Express. Published on August 9, 2012 as doi: /
ERJ Express. Published on August 9, 2012 as doi: 10.1183/09031936.00076912 Extracorporeal membrane oxygenation in a non intubated patient with acute respiratory distress syndrome (ARDS) Olaf Wiesner, *
More informationSurgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09
Surgery Grand Rounds Non-invasive Ventilation: A valuable tool James Cromie, PGY 3 8/24/09 History of mechanical ventilation 1930 s: use of iron lung 1940 s: First NIV system (Bellevue Hospital) 1950 s:
More informationQuando la NIV non basta. Andrea Vianello Fisiopatologia e Terapia Intensiva Respiratoria Ospedale-Università di Padova
Quando la NIV non basta Andrea Vianello Fisiopatologia e Terapia Intensiva Respiratoria Ospedale-Università di Padova Sixty-two RCTs including a total of 5870 patients Overall NIV failure: 16.3% NIV Real
More informationWhich mechanical assistance for cardiogenic shock?
Which mechanical assistance for cardiogenic shock? Alain Combes, MD, PhD, Hôpital Pitié-Salpêtrière, AP-HP Inserm UMRS 1166, ican, Institute of Cardiometabolism and Nutrition Pierre et Marie Curie Sorbonne
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationCurrent Management of Postpneumonectomy Bronchopleural Fistula
Current Management of Postpneumonectomy Bronchopleural Fistula Shaf Keshavjee MD MSc FRCSC FACS Surgeon-in-Chief, University Health Network James Wallace McCutcheon Chair in Surgery Professor, Division
More informationIn the setting of liver failure & transplantation?
ECMO: In the setting of liver failure & transplantation? Dr. Robert Loveridge MA LL.M MRCP FRCA FFICM Consultant in adult & liver intensive care medicine King s College Hospital NHS Foundation Trust What
More informationAcute Circulatory Support Should We or Shouldn t We?
Acute Circulatory Support Should We or Shouldn t We? Navin K. Kapur, MD, FACC, FSCAI Assistant Professor, Division of Cardiology Director, Acute Circulatory Support Program Director, Interventional Research
More informationTo ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW
To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004
More informationExtracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure
Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all
More informationLV Distension and ECLS Lungs
LV Distension and ECLS Lungs Kevin W. Hatton, MD, FCCM Interim Vice-Chair for Anesthesiology Research Division Chief, Anesthesiology Critical Care Medicine Program Director, Anesthesiology Critical Care
More informationTIMING FOR TRANSPLANT: ARE WE ALWAYS LATE?
SCDU CARDIOCHIRURGIA Università degli Studi di Torino Città della Salute e della Scienza Direttore: Prof. Mauro Rinaldi TIMING FOR TRANSPLANT: ARE WE ALWAYS LATE? Mauro Rinaldi LUNG TRANSPLANTATION Transplantation
More informationCystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012
Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 INTRODUCTION PNEUMOTHORAX HEMOPTYSIS RESPIRATORY FAILURE Cystic Fibrosis Autosomal Recessive Genetically
More informationManagement of Acute Shock and Right Ventricular Failure
Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK
More informationNIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity
NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Use of NIV 1998-2010 50 45 40 35 30 25 20 15 10 5 0 1998
More informationEvolution of Surgical Therapies for End-Stage Cardiopulmonary Failure. Heart Failure at the Shoe XI October 5, 2012
Evolution of Surgical Therapies for End-Stage Cardiopulmonary Failure Heart Failure at the Shoe XI October 5, 2012 Robert S.D. Higgins, MD, MSHA Executive Director, Comprehensive Transplant Center Evolution
More informationEcho assessment of patients with an ECMO device
Echo assessment of patients with an ECMO device Evangelos Leontiadis Cardiologist 1st Cardiology Dept. Onassis Cardiac Surgery Center Athens, Greece Gibbon HLM 1953 Goldstein DJ et al, NEJM 1998; 339:1522
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous
More informationSamphant Ponvilawan Bumrungrad International
Samphant Ponvilawan Bumrungrad International Definitions Artificial circulation using VA ECMO as an alternative to ventilation and external cardiac massage Indications Out-of-Hospital Cardiac Arrest (OHCA)
More informationEvolution of ECLS. 04/22/2016 Updated. AllinaHealthSystem. Minneapolis ECMO Early history. ELSO Member Centers
Evolution of ECLS Minneapolis 2016 Boston Children s Hospital Surgical Staff 1965 ECMO Early history Lab, 4 days ECC First cardiac case First newborn case(esperanza) 1965 1971 1972 1975 1980 First sucessful
More informationUpdate in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
More informationOption and Pitfalls in Cannulation for Extracorporeal Support
Option and Pitfalls in Cannulation for Extracorporeal Support The Regensburg Experience Extracorporeal Life Support Group Dept. of Anaesthesiology Dept. of Internal Medicine Dept. of Cardiothoracic Surgery
More informationEffects of mechanical ventilation on organ function. Masterclass ICU nurses
Effects of mechanical ventilation on organ function Masterclass ICU nurses Case Male, 60 - No PMH - L 1.74 m and W 85 kg Pneumococcal pneumonia Stable hemodynamics - No AKI MV in prone position (PEEP 16
More informationOutcome of extracorporeal membrane oxygenation as a bridge to lung transplantation: an institutional experience and literature review
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2015 Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation:
More informationDerivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: the EUROMACS-RHF Risk Score Osama I.I. Soliman, MD, PhD, FACC,
More informationThe FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation
The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation Susheel Kodali, MD Director, Structural Heart & Valve
More informationManagement of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist
Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic
More informationLung Volume Reduction Surgery. February 2013
Lung Volume Reduction Surgery February 2013 Presentation Outline Lung Volume Reduction Surgery (LVRS) Rationale & Historical Perspective NETT Results Current LVRS Process (from referral to surgery) Diagnostic
More informationECMO- ExtraCorporeal Membrane Oxygenation
05/04/203 ECMO- ExtraCorporeal Membrane Oxygenation ECMO AS BRIDGE TO LUNG TRANSPLANTATION: PHYSIOTHERAPEUTIC INTERVENTION Sara Mariani Physiotherapist Fondazione IRCCS Ospedale Maggiore Policlinico Milano
More informationECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH
ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate Carolyn Calfee, MD MAS Mark Eisner, MD MPH June 3, 2010 Case Presentation Setting: Community hospital, November 2009 29 year old woman with
More informationExtracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis
Featured Article Extracorporeal membrane oxygenation after lung transplantation: risk factors and outcomes analysis Massimo Boffini 1, Erika Simonato 1, Davide Ricci 1, Fabrizio Scalini 1, Matteo Marro
More informationECMO for Refractory Septic Shock Prof. Alain Combes
ECMO for Refractory Septic Shock Prof. Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie, Paris
More informationKeeping Patients Off the Vent: Bilevel, HFNC, Neither?
Keeping Patients Off the Vent: Bilevel, HFNC, Neither? Robert Kempainen, MD Pulmonary and Critical Care Medicine Hennepin County Medical Center University of Minnesota School of Medicine Objectives Summarize
More informationOptimizing the Lung Transplant Candidate through Exercise Training. Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014
Optimizing the Lung Transplant Candidate through Exercise Training Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014 Conflicts of Interest None to declare Learning Objectives At
More informationECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan
ECMO as a bridge to durable LVAD therapy Jonathan Haft, MD Department of Cardiac Surgery University of Michigan Systolic Heart Failure Prevalence 4.8 million U.S. 287,000 deaths per year $39 billion spent
More informationเอกราช อร ยะช ยพาณ ชย
30 July 2016 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Disclosure Speaker, CME service: Merck, Otsuka, Servier Consultant, non-cme service: Novartis, Menarini
More informationOxygen and ABG. Dr Will Dooley
Oxygen and ABG G Dr Will Dooley Oxygen and ABGs Simply in 10 cases Recap of: ABG interpretation Oxygen management Some common concerns A-a gradient Base Excess Anion Gap COPD patients CPAP/BiPAP First
More informationSociety of Thoracic Surgeons Implementation of a Surgical Curriculum in Cardiothoracic Surgery January 27, 2014
Creating an Integrated 6 Year Cardiothoracic Curriculum 264 Weeks John S. Ikonomidis, MD, PhD, FRCS(C), FACS, FAHA, FACC Horace G. Smithy Professor and Chief, Cardiothoracic Surgery Medical University
More informationInhaled nitric oxide: clinical evidence for use in adults
Inhaled nitric oxide: clinical evidence for use in adults Neill Adhikari Critical Care Medicine Sunnybrook Health Sciences Centre and University of Toronto 31 October 2014 Conflict of interest Ikaria provided
More informationDisclosures. Extra-Corporeal Membrane Oxygenation During Cardio- Pulmonary Resuscitation ECPR April 22, 2016 ECG. Case. Case. Case Summary 4/22/2016
Extra-Corporeal Membrane Oxygenation During Cardio- Pulmonary Resuscitation ECPR April 22, 2016 Nothing to disclose. Disclosures Ivan J Chavez MD Case ECG History 60 y/o male No prior history of CAD In
More informationECCO 2 Removal The Perfusionists Perspective
ECCO 2 Removal The Perfusionists Perspective BelSECT Education evening 2016-06-15 D. Hella, Th. Amand, J-N Koch Definition ECCO 2 Removal: Process by which an extracorporeal circuit is used for removing
More informationOSCAR & OSCILLATE. & the Future of High Frequency Oscillatory Ventilation (HFOV)
& & the Future of High Frequency Oscillatory Ventilation (HFOV) www.philippelefevre.com What do we know already? Sud S et al. BMJ 2010 & Multi-centre randomised controlled trials of HFOV verses current
More informationBest of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine
Best of Pulmonary 2012-2013 Jennifer R. Hucks, MD University of South Carolina School of Medicine Topics ARDS- Berlin Definition Prone Positioning For ARDS Lung Protective Ventilation In Patients Without
More informationEchocardiographic Structural Assessment Pre- LVAD
None Disclosures Echocardiographic Structural Assessment Pre- LVAD LVEF ( 25% for DT LVAD) Right ventricle Valvular disease Intra- cardiac shunts Intra- cardiac thrombi Ascending aorta Case 1 50 yo M
More informationMechanical Support in the Failing Fontan-Kreutzer
Mechanical Support in the Failing Fontan-Kreutzer Stephanie Fuller MD, MS Thomas L. Spray Endowed Chair in Congenital Heart Surgery Associate Professor, The Perelman School of Medicine at the University
More informationPEEP recruitment maneuver
Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF Case 1: 40 yo Male restrained driver high speed MVA P 140, RR 40 labored, BP 100/70, O 2 sat 70 Chest wheeze, crackles
More informationPost-Resuscitation Care. Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena
Post-Resuscitation Care Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena Conflict of interest Emcools Shareholder and founder, honoraria Zoll: honoraria Bard: honoraria, nephew works
More informationECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit
ECMO CPR Ravi R. Thiagarajan MBBS, MPH Staff Intensivist Cardiac Intensive Care Unit Children s Hospital Boston PCICS 2008, Miami, FL No disclosures Disclosures Outline Outcomes for Pediatric in-hospital
More informationBASIC CRITICAL CARE OF THE PATIENT. Hannelisa Callisen PA C February 2017
BASIC CRITICAL CARE OF THE PATIENT Hannelisa Callisen PA C February 2017 Disclosures Industry: None ECMO is off label Objectives ECMO initiation selection, cannulation Physiology : Review of DO2 on ECMO
More informationSession 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019
Session 1: Circuit, Anticoagulation and Monitoring Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019 Goals n Learn how to set up citrate anticoagulation for CVVH, CVVHD, CVVHDF using Prismaflex n Determine
More informationDocumenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC
Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC 2017 NPSS Asheville, NC Objectives Understand the importance of documenting to the highest specificity Understand
More informationInhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients
Journal of Critical Care (2013) 28, 844 848 Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients Heather Torbic PharmD, BCPS a,, Paul M. Szumita PharmD, BCPS
More informationCASE PRESENTATION VV ECMO
CASE PRESENTATION VV ECMO Joshua Huelster, MD Fellow in Critical Care Medicine Department of Pulmonary and Critical Care Medicine Hennepin County Medical Center Disclosure There are no conflicts of interest
More informationChris Cameron Clinical pharmacologist & General Physician CCDHB. Oxygen- A prescribing Blindspot?
Chris Cameron Clinical pharmacologist & General Physician CCDHB Oxygen- A prescribing Blindspot? Ms J, 70yo Lives with partner, who has a recent diagnosis of breast cancer Works 3 days a week Weight 46kg
More informationACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE
More informationMatching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support
Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced
More information